Drug name - Kybella
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8242294 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
May, 2028
(5 years from now) | |
| CN101711254A | KYTHERA BIOPHARMS | Synthetic Bile Acid Composition, Method, And Preparation |
Oct, 2016
(5 years ago) | |
| CN108191940B | KYTHERA BIOPHARMS | Synthetic Bile Acid Compositions, Methods And Formulations |
Jun, 2028
(5 years from now) | |
| CN106083969A | KYTHERA BIOPHARMS | Synthetic Bile Acid Composition, Method And Preparation |
Jun, 2028
(5 years from now) | |
| CN106083969B | KYTHERA BIOPHARMS | Synthetic Bile Acid Composition, Method And Preparation |
Jun, 2028
(5 years from now) | |
| CN108191940A | KYTHERA BIOPHARMS | Synthetic Bile Acid Composition, Method And Preparation |
Jun, 2028
(5 years from now) | |
| EP3002290A2 | KYTHERA BIOPHARMS | Synthesis Of Deoxycholic Acid (Dca) |
Jun, 2028
(5 years from now) | |
| EP2407475B1 | KYTHERA BIOPHARMS | Synthetic Bile Acid Preparation |
Jun, 2028
(5 years from now) | |
| EP3002290A3 | KYTHERA BIOPHARMS | Synthesis Of Deoxycholic Acid (Dca) |
Jun, 2028
(5 years from now) | |
| EP2407475A3 | KYTHERA BIOPHARMS | Synthetic Bile Acid Composition, Method, And Preparation |
Jun, 2028
(5 years from now) | |
| EP3002290B1 | KYTHERA BIOPHARMS | Synthesis Of Deoxycholic Acid (Dca) |
Jun, 2028
(5 years from now) | |
| EP2407475A2 | KYTHERA BIOPHARMS | Synthetic Bile Acid Preparation |
Jun, 2028
(5 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8846066 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat and skin tightening |
Feb, 2025
(2 years from now) | |
| US8298556 | KYTHERA BIOPHARMS | Methods and related compositions for the non-surgical removal of fat |
Aug, 2025
(2 years from now) | |
| US7622130 | KYTHERA BIOPHARMS | Methods and compositions for the non-surgical removal of fat |
Dec, 2027
(5 years from now) | |
| US7754230 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat |
Dec, 2027
(5 years from now) | |
| US8546367 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9949986 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9636349 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9522155 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8461140 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8883770 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8653058 | KYTHERA BIOPHARMS | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Mar, 2030
(7 years from now) | |
| US8101593 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
| US8367649 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
| US10500214 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
Drugs and Companies using DEOXYCHOLIC ACID ingredient
Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as described in the approved labeling
Dosage: SOLUTION;SUBCUTANEOUS
| Strength | Dosage | Availability |
|---|---|---|
| 20MG/2ML (10MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.